phenelzine has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, K | 1 |
| Luo, J | 2 |
| Yeh, S | 1 |
| You, B | 1 |
| Meng, J | 1 |
| Chang, P | 1 |
| Niu, Y | 1 |
| Li, G | 1 |
| Lu, C | 1 |
| Zhu, Y | 1 |
| Antonarakis, ES | 1 |
| Huang, CP | 1 |
| Xu, W | 1 |
| Chang, C | 1 |
| Gaur, S | 1 |
| Gross, ME | 1 |
| Liao, CP | 1 |
| Qian, B | 1 |
| Shih, JC | 1 |
2 other studies available for phenelzine and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer.
Topics: Alternative Splicing; Animals; Benzamides; Cell Line, Tumor; Cell Proliferation; Clorgyline; Drug Re | 2020 |
Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.
Topics: Androgen Antagonists; Benzamides; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Clorgyline; | 2019 |